This second one may actually have some new data in it - the first will not (a previously reported animal study).
They should now be at a stage they can provide somewhat final results regarding the measured viral and immune response during the CALM extension study.
However the big news required remains immune response from the STORM study (intravenous). Off the back of that perhaps combined with some early info from human combo trials, we need to see partnering.
- Forums
- ASX - By Stock
- VLA
- Vienna Conference Looks Promising
Vienna Conference Looks Promising, page-11
Featured News
Add VLA (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
CC9
CHARIOT CORPORATION LTD
Shanthar Pathmanathan, MD
Shanthar Pathmanathan
MD
Previous Video
Next Video
SPONSORED BY The Market Online